The target audience for this initiative is physicians and other providers, including nurse practitioners and physician assistants, who may encounter patients in their practice with undiagnosed TTR amyloidosis.Learn about TTR Amyloidosis – including how to shorten individuals’ diagnostic journey and the time till they access treatment which might improve their quality of life or even prevent…
Yuliya Linhares, MD, Chief of Lymphoma Services at Miami Cancer Institute, discusses strategies for shortening the diagnostic journey of CTCL.
Jean Donadieu, MD Service d’Hémato-Oncologie Pédiatrique, Hopital, Paris, provides an overview of WHIM syndrome.
Larisa Geskin, MD, Columbia University Medical Center and Comprehensive Skin Cancer Center at the Division of Cutaneous Oncology in the Department of Dermatology, discusses the…
Aleena Banerji, MD, highlights the current treatment options for patients with hereditary angioedema (HAE) based on available guidelines.
This Webinar examines what is PEGylation and the clinical uses of therapeutic proteins, and their applications in healthcare.
Nicholas Silvestri, MD, of the Univ of Buffalo, provides an overview of the latest myasthenia gravis clinical research presented at AAN 2024.
Learn about the challenges of finding suitable candidates for gene therapy clinical trials, and limitations of ERT for MPS.
Marina Kremyanskaya, MD, PhD, discusses the development of gene silencer divesiran for treatment of polycythemia vera (PV).
John Kuruvilla, MD, explores best practices for discussing possible clinical trial participation with patients with hematologic malignancies
